FRIDAY, Nov. 22, 2024 (HealthDay News) -- For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or ...

Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo. (HealthDay News) — For patients with heart failure with preserved ...

The finding could open the door ... Weight-Loss Drug Reduces Risk of Early Death for Patients With Heart Failure, Trial Finds Nov. 20, 2024 — Weight-loss and diabetes drug tirzepatide can reduce ...

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

MONDAY, Nov. 25, 2024 (HealthDay News) -- Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology ...

Martha Atienza's single-channel video Our Islands 11°16'58.4 N 123°45'07.0'E (2017) shows an underwater procession based on the Ati-atihan festival, w ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well ... are in NYHA class I/II, 23% vs 26% are in NYHA class III/IV; at 1 year, 84% perindopril ...

Dec. 2, 2021 — Human heart muscle cells cease to multiply after birth, making any heart injury later in life a permanent one, reducing function and leading to heart failure. Now, however ...